Published in JAMA Internal Medicine · View the paper (DOI)
A cohort study found no association between GLP-1 receptor agonist use and increased risk of suicide death or related disorders in patients with type 2 diabetes. The study included mostly patients with type 2 diabetes.
Coverage from 2 institutions